The FX PostThe FX Post
    What's Hot

    Risk mitigation

    July 18, 2025

    Cloud mining revolutionizes the way to increase the value of crypto assets: Ripplecoin Mining allows XRP, BTC, and Solana holders to achieve daily income | Business Upturn

    July 17, 2025

    Republicans declared it ‘crypto’ week in the House. It’s not going as planned

    July 16, 2025
    The FX Post The FX Post
    • Best Fx Robots
    • Forex
      • News
      • Forex 101
      • Forex Forecasts
      • Broker Reviews
    • Crypto
      • News
      • Crypto 101
      • Crypto Forecasts
      • Crypto Reviews
    • Indices
      • News
      • Analysis
      • Commodities
      • Reviews
    • Automated Trading
      • Forex Signals
      • Forex Robots
      • Copy Trading
    • Top
      • Best Forex Robots
    The FX PostThe FX Post
    Home ยป AbbVie to Acquire ImmunoGen Inc.
    News

    AbbVie to Acquire ImmunoGen Inc.

    November 30, 20231 Min Read
    Facebook Twitter Pinterest LinkedIn Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Reddit

    AbbVie Inc. (Ticker: ABBV) has announced an agreement to acquire cancer treatment developer ImmunoGen Inc. (Ticker: IMGN) in a cash deal valued at $10.1 billion.

    Deal Details

    Under the terms of the agreement, AbbVie will pay $31.26 in cash for each outstanding share of ImmunoGen. This offer represents a significant 94.6% premium to Wednesday’s closing price of $16.06 per share. AbbVie’s shares slipped 0.4% in premarket trading after the news, while trading of ImmunoGen’s stock was halted until 8 a.m. Eastern.

    The deal includes ImmunoGen’s highly regarded cancer therapy, Elahere, which has already received approval as a treatment for ovarian cancer. AbbVie expects the acquisition to be completed in the middle of 2024, with the transaction contributing to earnings by 2027.

    Long-Term Growth Strategy

    AbbVie’s Chief Executive, Richard Gonzalez, emphasized the importance of this acquisition in fulfilling the company’s long-term growth strategy. He stated, “The acquisition of ImmunoGen demonstrates our commitment to diversifying our oncology pipeline across solid tumors and hematologic malignancies.”

    Impressive Year for ImmunoGen

    ImmunoGen has experienced exceptional growth, with its stock skyrocketing by 223.8% year-to-date through Wednesday. In contrast, AbbVie shares have dipped by 14.3%, while the S&P 500 has advanced 18.5%.

    Markets are invaded by algorithms
    Secure your passive income with algo-based trading systems
    Learn more
    AbbVie Inc. cancer treatment ImmunoGen Inc. oncology
    Share. Facebook Twitter Pinterest LinkedIn Reddit

    Related Posts

    Risk mitigation

    July 18, 2025

    Cloud mining revolutionizes the way to increase the value of crypto assets: Ripplecoin Mining allows XRP, BTC, and Solana holders to achieve daily income | Business Upturn

    July 17, 2025

    Republicans declared it ‘crypto’ week in the House. It’s not going as planned

    July 16, 2025

    SIM Mining Announces Global Launch of Next-Gen Cloud Mining Platform!

    July 15, 2025
    Add A Comment

    Leave A Reply Cancel Reply

    97  −    =  95

    Best FX Post
    Best Forex Robots (Expert Advisors) 2021

    Best Forex Robots (Expert Advisors) 2022: Passive Income From Algo Trading Systems

    July 7, 2021

    Top 10 Lending Platforms for Crypto Loans

    June 1, 2022
    forex eurusd trading charts

    Top 10 Best Forex Brokers In All Times

    June 1, 2022
    Recent Posts
    • Risk mitigation
    • Cloud mining revolutionizes the way to increase the value of crypto assets: Ripplecoin Mining allows XRP, BTC, and Solana holders to achieve daily income | Business Upturn
    • Republicans declared it ‘crypto’ week in the House. It’s not going as planned
    • SIM Mining Announces Global Launch of Next-Gen Cloud Mining Platform!
    • RICH Miner leads the Ripple cloud mining revolution – converting XRP into daily stable income
    Featured Reviews

    Traders Connect Review

    May 18, 2023

    System Levels Review

    May 26, 2023
    TechBerry

    TechBerry Review: Pros, Cons, Recommendations

    September 18, 2021
    Categories
    • Analysis
    • Automated Trading
    • Best FX Post
    • Broker Reviews
    • Commodities
    • Copy Trading
    • Crypto
    • Crypto 101
    • Crypto Bots
    • Crypto Forecasts
    • Crypto Reviews
    • Crypto Robot
    • Forex
    • Forex 101
    • Forex Forecasts
    • Forex Robots
    • Forex Signals
    • Forex Signals
    • Guides
    • Indices
    • News
    • News
    • News
    • News
    • Reviews
    • Reviews
    • Uncategorized
    Twitter BlogLovin
    © 2025, Thefxpost.com.
    • Contact

    Type above and press Enter to search. Press Esc to cancel.